| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 8.178 | 5.299 | 2.874 | 28.563 | 3.676 |
| Total Income - EUR | - | - | - | - | 0 | 8.178 | 5.299 | 2.874 | 28.566 | 3.681 |
| Total Expenses - EUR | - | - | - | - | 1.002 | 11.373 | 11.105 | 5.534 | 9.188 | 11.962 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.002 | -3.194 | -5.806 | -2.660 | 19.378 | -8.281 |
| Net Profit/Loss - EUR | - | - | - | - | -1.002 | -3.434 | -5.965 | -2.746 | 15.705 | -8.323 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Columbo Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 27.767 | 21.700 | 15.802 | 10.416 | 4.967 | 0 |
| Current Assets | - | - | - | - | 985 | 3.224 | 2.799 | 5.502 | 30.288 | 23.131 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 7 | 151 |
| Cash | - | - | - | - | 985 | 3.224 | 2.799 | 5.502 | 30.281 | 22.980 |
| Shareholders Funds | - | - | - | - | -960 | -4.376 | -10.244 | -13.022 | 2.723 | -5.615 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 29.713 | 29.300 | 28.845 | 28.939 | 32.531 | 28.746 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Columbo Medical S.r.l.